{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T16:21:13Z","timestamp":1791649273072,"version":"4.3.4"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20161399"],"award-info":[{"award-number":["BK20161399"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81330079"],"award-info":[{"award-number":["81330079"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81673487"],"award-info":[{"award-number":["81673487"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81473221"],"award-info":[{"award-number":["81473221"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21472091"],"award-info":[{"award-number":["21472091"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["020814380076"],"award-info":[{"award-number":["020814380076"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.bcp.2018.01.033","type":"journal-article","created":{"date-parts":[[2018,2,2]],"date-time":"2018-02-02T08:48:05Z","timestamp":1517561285000},"page":"269-281","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["A novel combination of astilbin and low-dose methotrexate respectively targeting A2AAR and its ligand adenosine for the treatment of collagen-induced arthritis"],"prefix":"10.1016","volume":"153","author":[{"given":"Yuxiang","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefeng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingxin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xudong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2018.01.033_b0005","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0140-6736(10)60826-4","article-title":"Rheumatoid arthritis","volume":"376","author":"Scott","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.bcp.2018.01.033_b0010","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/ard.2005.044354","article-title":"EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)","volume":"66","author":"Combe","year":"2007","journal-title":"Ann. Rheumatic Dis."},{"key":"10.1016\/j.bcp.2018.01.033_b0015","doi-asserted-by":"crossref","first-page":"6232","DOI":"10.1073\/pnas.0808144106","article-title":"In vivo activated monocytes from the site of inflammation in humans specifically promote Th17 responses","volume":"106","author":"Evans","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bcp.2018.01.033_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00296-013-2848-3","article-title":"German guidelines for the sequential medical treatment of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs","volume":"34","author":"Albrecht","year":"2014","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.bcp.2018.01.033_b0025","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/art.23721","article-title":"American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis","volume":"59","author":"Saag","year":"2008","journal-title":"Arthrit. Rheumatism."},{"key":"10.1016\/j.bcp.2018.01.033_b0030","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1136\/ard.2008.093690","article-title":"Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research","volume":"68","author":"Salliot","year":"2009","journal-title":"Ann. Rheumatic Dis."},{"key":"10.1016\/j.bcp.2018.01.033_b0035","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1093\/rheumatology\/kei031","article-title":"A meta-analysis of the efficacy and toxicity of combining disease-modifying anti-rheumatic drugs in rheumatoid arthritis based on patient withdrawal","volume":"44","author":"Choy","year":"2005","journal-title":"Rheumatol. (Oxford, England)"},{"key":"10.1016\/j.bcp.2018.01.033_b0040","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1002\/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO;2-W","article-title":"Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis","volume":"41","author":"Maini","year":"1998","journal-title":"Arthrit. Rheumatism."},{"key":"10.1016\/j.bcp.2018.01.033_b0045","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1211\/0022357023033","article-title":"Astilbin prevents concanavalin A-induced liver injury by reducing TNF-alpha production and T lymphocytes adhesion","volume":"56","author":"Wang","year":"2004","journal-title":"J. Pharmacy Pharmacol."},{"key":"10.1016\/j.bcp.2018.01.033_b0050","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s00011-003-1179-3","article-title":"Astilbin suppresses collagen-induced arthritis via the dysfunction of lymphocytes","volume":"52","author":"Cai","year":"2003","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.bcp.2018.01.033_b0055","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.jaci.2005.08.032","article-title":"Astilbin inhibits contact hypersensitivity through negative cytokine regulation distinct from cyclosporin A","volume":"116","author":"Fei","year":"2005","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.bcp.2018.01.033_b0060","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1006\/phrs.2001.0838","article-title":"Astilbin selectively facilitates the apoptosis of interleukin-2-dependent phytohemagglutinin-activated Jurkat cells","volume":"44","author":"Yan","year":"2001","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bcp.2018.01.033_b0065","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.intimp.2008.06.006","article-title":"Astilbin inhibits the adhesion of T lymphocytes via decreasing TNF-alpha and its associated MMP-9 activity and CD44 expression","volume":"8","author":"Yi","year":"2008","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bcp.2018.01.033_b0070","doi-asserted-by":"crossref","first-page":"4562","DOI":"10.1021\/jf2002969","article-title":"Isolation and characterization of two flavonoids, engeletin and astilbin, from the leaves of Engelhardia roxburghiana and their potential anti-inflammatory properties","volume":"59","author":"Huang","year":"2011","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.bcp.2018.01.033_b0075","first-page":"8246420","article-title":"Astilbin from Smilax glabra Roxb. Attenuates inflammatory responses in complete freund's adjuvant-induced arthritis rats","volume":"2017","author":"Dong","year":"2017","journal-title":"eCAM"},{"key":"10.1016\/j.bcp.2018.01.033_b0080","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1007\/s10875-011-9542-6","article-title":"Combined treatment of etanercept and MTX reverses Th1\/Th2, Th17\/Treg imbalance in patients with rheumatoid arthritis","volume":"31","author":"Lina","year":"2011","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.bcp.2018.01.033_b0085","doi-asserted-by":"crossref","first-page":"238035","DOI":"10.1155\/2013\/238035","article-title":"Combination with methotrexate and cyclophosphamide attenuated maturation of dendritic cells: inducing Treg skewing and Th17 suppression in vivo","volume":"2013","author":"Yu","year":"2013","journal-title":"Clin. Develop. Immunol."},{"key":"10.1016\/j.bcp.2018.01.033_b0090","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1124\/pr.57.2.3","article-title":"Low-dose methotrexate: a mainstay in the treatment of rheumatoid arthritis","volume":"57","author":"Cronstein","year":"2005","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bcp.2018.01.033_b0095","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.it.2003.11.003","article-title":"Adenosine: an endogenous regulator of innate immunity","volume":"25","author":"Hasko","year":"2004","journal-title":"Trends Immunol."},{"key":"10.1016\/j.bcp.2018.01.033_b0100","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0031-6997(24)01511-4","article-title":"International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors","volume":"53","author":"Fredholm","year":"2001","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bcp.2018.01.033_b0105","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1055\/s-1999-13963","article-title":"A new flavanone isolated from rhizoma smilacis glabrae and the structural requirements of its derivatives for preventing immunological hepatocyte damage","volume":"65","author":"Chen","year":"1999","journal-title":"Planta Medica."},{"key":"10.1016\/j.bcp.2018.01.033_b0110","doi-asserted-by":"crossref","first-page":"4969","DOI":"10.4049\/jimmunol.1300832","article-title":"A novel disease-modifying antirheumatic drug, iguratimod, ameliorates murine arthritis by blocking IL-17 signaling, distinct from methotrexate and leflunomide","volume":"191","author":"Luo","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.bcp.2018.01.033_b0115","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ni.2416","article-title":"Induction and molecular signature of pathogenic TH17 cells","volume":"13","author":"Lee","year":"2012","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bcp.2018.01.033_b0120","doi-asserted-by":"crossref","DOI":"10.1002\/tera.1420450109","article-title":"Effects of (R)-deoxycoformycin (pentostatin) on intrauterine nucleoside catabolism and embryo viability in the pregnant mouse","author":"Knudsen","year":"1992","journal-title":"Teratology"},{"key":"10.1016\/j.bcp.2018.01.033_b0125","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nri2094","article-title":"Cytokines in the pathogenesis of rheumatoid arthritis","volume":"7","author":"McInnes","year":"2007","journal-title":"Nat. Rev. Immunol."},{"issue":"Suppl 6","key":"10.1016\/j.bcp.2018.01.033_b0130","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/kes278","article-title":"Evolution of treatment for rheumatoid arthritis","volume":"51","author":"Upchurch","year":"2012","journal-title":"Rheumatology (Oxford, England)"},{"key":"10.1016\/j.bcp.2018.01.033_b0135","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1136\/ard.2008.099861","article-title":"Efficacy and toxicity of methotrexate (MTX) monotherapy versus MTX combination therapy with non-biological disease-modifying antirheumatic drugs in rheumatoid arthritis: a systematic review and meta-analysis","volume":"68","author":"Katchamart","year":"2009","journal-title":"Ann. Rheumatic Dis."},{"key":"10.1016\/j.bcp.2018.01.033_b0140","first-page":"S95","article-title":"Side effects and management of side effects of methotrexate in rheumatoid arthritis","volume":"28","author":"Albrecht","year":"2010","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.bcp.2018.01.033_b0145","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1002\/art.1780381213","article-title":"Comparison of azathioprine, methotrexate, and the combination of the two in the treatment of rheumatoid arthritis. A forty-eight-week controlled clinical trial with radiologic outcome assessment","volume":"38","author":"Willkens","year":"1995","journal-title":"Arthrit. Rheumatism."},{"key":"10.1016\/j.bcp.2018.01.033_b0150","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1002\/art.21018","article-title":"A 48-week, randomized, double-blind, double-observer, placebo-controlled multicenter trial of combination methotrexate and intramuscular gold therapy in rheumatoid arthritis: results of the METGO study","volume":"52","author":"Lehman","year":"2005","journal-title":"Arthrit. Rheumatism."},{"key":"10.1016\/j.bcp.2018.01.033_b0155","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1136\/ard.58.4.220","article-title":"Combination therapy in early rheumatoid arthritis: a randomised, controlled, double blind 52 week clinical trial of sulphasalazine and methotrexate compared with the single components","volume":"58","author":"Dougados","year":"1999","journal-title":"Ann. Rheumatic Dis."},{"key":"10.1016\/j.bcp.2018.01.033_b0160","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/rheumatology\/33.11.1049","article-title":"Combination of methotrexate and sulphasalazine vs methotrexate alone: a randomized open clinical trial in rheumatoid arthritis patients resistant to sulphasalazine therapy","volume":"33","author":"Haagsma","year":"1994","journal-title":"British J. Rheumatol."},{"key":"10.1016\/j.bcp.2018.01.033_b0165","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1093\/rheumatology\/36.10.1082","article-title":"Combination of sulphasalazine and methotrexate versus the single components in early rheumatoid arthritis: a randomized, controlled, double-blind, 52 week clinical trial","volume":"36","author":"Haagsma","year":"1997","journal-title":"British J. Rheumatol."},{"key":"10.1016\/j.bcp.2018.01.033_b0170","doi-asserted-by":"crossref","first-page":"726","DOI":"10.7326\/0003-4819-137-9-200211050-00007","article-title":"Concomitant leflunomide therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate. A randomized, double-blind, placebo-controlled trial","volume":"137","author":"Kremer","year":"2002","journal-title":"Ann. Internal Med."},{"key":"10.1016\/j.bcp.2018.01.033_b0175","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/nrrheum.2013.205","article-title":"Of mice and men: how animal models advance our understanding of T-cell function in RA","volume":"10","author":"Kobezda","year":"2014","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.bcp.2018.01.033_b0180","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.jbspin.2008.04.005","article-title":"Shifting the imbalance from Th1\/Th2 to Th17\/treg: the changing rheumatoid arthritis paradigm","volume":"75","author":"Boissier","year":"2008","journal-title":"Joint, Bone, Spine: Revue du Rhumatisme"},{"key":"10.1016\/j.bcp.2018.01.033_b0185","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1136\/ard.2005.048637","article-title":"Methotrexate modulates the kinetics of adenosine in humans in vivo","volume":"65","author":"Riksen","year":"2006","journal-title":"Ann. Rheumatic Dis."},{"key":"10.1016\/j.bcp.2018.01.033_b0190","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1002\/art.22643","article-title":"The antiinflammatory mechanism of methotrexate depends on extracellular conversion of adenine nucleotides to adenosine by ecto-5'-nucleotidase: findings in a study of ecto-5'-nucleotidase gene-deficient mice","volume":"56","author":"Montesinos","year":"2007","journal-title":"Arthrit. Rheumatism."},{"key":"10.1016\/j.bcp.2018.01.033_b0195","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1182\/blood-2007-03-081646","article-title":"A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells","volume":"111","author":"Zarek","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2018.01.033_b0200","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.bcp.2015.08.092","article-title":"Caffeine promotes anti-tumor immune response during tumor initiation: involvement of the adenosine A2A receptor","volume":"98","author":"Eini","year":"2015","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2018.01.033_b0205","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000317068","article-title":"Effects of adenosine A(2A) and A(2B) receptor activation on signaling pathways and cytokine production in human uroepithelial cells","volume":"86","author":"Save","year":"2010","journal-title":"Pharmacology"},{"key":"10.1016\/j.bcp.2018.01.033_b0210","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.cellsig.2017.04.014","article-title":"Adenosine A2A receptor modulates neuroimmune function through Th17\/retinoid-related orphan receptor gamma t (RORgammat) signaling in a BTBR T+ Itpr3tf\/J mouse model of autism","volume":"36","author":"Ansari","year":"2017","journal-title":"Cell. Sign."},{"key":"10.1016\/j.bcp.2018.01.033_b0215","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1111\/bph.12227","article-title":"Activation of adenosine A(2A) receptor reduces osteoclast formation via PKA- and ERK1\/2-mediated suppression of NFkappaB nuclear translocation","volume":"169","author":"Mediero","year":"2013","journal-title":"British J. Pharmacol."},{"key":"10.1016\/j.bcp.2018.01.033_b0220","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1189\/jlb.2VMA1216-517R","article-title":"Early tyrosine phosphorylation events following adenosine A2A receptor in human neutrophils: identification of regulated pathways","volume":"102","author":"Giambelluca","year":"2017","journal-title":"J. Leukocyte Biol."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295218300339?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295218300339?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:01:43Z","timestamp":1757768503000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295218300339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":44,"alternative-id":["S0006295218300339"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2018.01.033","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel combination of astilbin and low-dose methotrexate respectively targeting A2AAR and its ligand adenosine for the treatment of collagen-induced arthritis","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2018.01.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}